Author: Melander A.
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.34, Iss.3, 1998-03, pp. : 181-188
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Hepatotoxicity with Thiazolidinediones: Is it a Class Effect?
By Scheen A.J.
Drug Safety, Vol. 24, Iss. 12, 2001-01 ,pp. :
Time to consider placebo effect in QOL studies in NSCLC?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 327, 2001-01 ,pp. :
Antiretroviral triple therapy: beneficial effect on body composition?
Inpharma, Vol. 1, Iss. 1221, 2000-01 ,pp. :